WHO said Omicron spreading at a rate we have not seen with any previous Variant
The World Health Organization (WHO) on Tuesday said that the Omicron variant of coronavirus is spreading at a rate not seen with any previous variant. This statement of Tedros Adhanom Ghebreyesus put people into more fear about omicron.
In a media briefing, Tedros Adhanom Ghebreyesus, Director general of WHO, said, “77 countries have now reported cases of Omicron, and the reality is that Omicron is probably in most countries, even if it hasn’t been detected yet. Omicron is spreading at a rate we have not seen with any previous variant.”
WHO urged that countries can and must prevent the spread of Omicron with measures that work. Vaccines alone will not get any country out of this crisis.
The WHO chief further said, “We’re concerned that people are dismissing Omicron as mild. Surely, we have learned by now that we underestimate this virus at our peril. Even if Omicron does cause less severe disease, the sheer number of cases could once again overwhelm unprepared health systems.”
He reiterated, “It’s not vaccines instead of masks. It’s not vaccines, instead of distancing. It’s not vaccines instead of ventilation or hand hygiene. Do it all. Do it consistently. Do it well”
Also Read: Google Chrome browser users Govt issues urgent warning
The WHO said it is not against booster shots but against the inequity. “The emergence of Omicron has prompted some countries to roll out Covid-19 booster programmes for their entire adult populations, even while we lack evidence for the effectiveness of boosters against this variant.”
Pfizer Vaccine Cuts Omicron Hospitalisation By 70% in South Africa. Early indicators suggest that it could be more transmissible, but promising data so far has suggested that vaccines still offer protection against Omicron.
Also Read: Karnataka: Provide ‘Fake’ Omicron negative RT-PCR Report for Patient, 4 people arrested
The latest research out of South Africa suggested that two doses of the Pfizer/BioNTech vaccine still offered protection against serious illness. “The double dose of Pfizer/BioNTech vaccine showing 70 percent effectiveness in reducing risk of hospitalisation,” said Ryan Noach, the head of South Africa’s leading private health insurance company, Discovery, which co-led the study.
Two doses of the vaccine offered 93 percent protection against earlier variants, according to the companies. The study was based on the results of 78,000 PCR tests taken in South Africa between November 15 and December 7 and was conducted by Discovery along with the South African Medical Research Council (SAMRC).
Comments are closed.